Taxonomic group: bacteria / Firmicutes
(Phylum: Firmicutes)
Associated disease: dental caries [ICD11:
DA08.0 
];
infection due to Streptococcus mutans [ICD11:
XN2RH 
]
The structure was elucidated in this paperNCBI PubMed ID: 28971282Publication DOI: 10.1007/s10719-017-9798-zJournal NLM ID: 8603310Publisher: Kluwer Academic Publishers
Correspondence: Andrew.Cox

nrc-cnrc.gc.ca
Institutions: Vaccine Program, Human Health Therapeutics Portfolio, National Research Council, 100, Sussex Drive, National Research Council, Ottawa, ON, K1A 0R6, Canada
Dental caries remains a major health issue and the Gram-positive bacterium Streptococcus mutans is considered as the major pathogen causing caries. More recently, S. mutans has been recognised as a cause of endocarditis, ulcerative colitis and fatty acid liver disease along with the likelihood of increased cerebral hemorrhage following a stroke if S. mutans is present systemically. We initiated this study to examine the vaccine candidacy of the serotype specific polysaccharides elaborated by S. mutans. We have confirmed the carbohydrate structures for the serotype specific rhamnan containing polysaccharides from serotypes c, f and k. We have prepared glycoconjugate vaccines using the rhamnan containing polymers from serotypes f and k and immunised mice and rabbits. We consistently obtained a robust immune response to the glycoconjugates with cross-reactivity consistent with the structural similarities of the polymers from the different serotypes. We developed an opsonophagocytic assay which illustrated the ability of the post-immune sera to facilitate opsonophagocytic killing of the homologous and heterologous serotypes at titers consistent with the structural homologies. We conclude that glycoconjugates of the rhamnan polymers of S. mutans are a potential vaccine candidate to target dental caries and other sequelae following the escape of S. mutans from the oral cavity.
conjugate vaccine, rhamnan, Serotype polysaccharide, Streptococcus mutans
Structure type: polymer chemical repeating unit
Location inside paper: table 1, p.56, fig.1
Trivial name: galactorhamnan
Contained glycoepitopes: IEDB_133754,IEDB_136105,IEDB_136906,IEDB_137472,IEDB_141794,IEDB_143254,IEDB_151528,IEDB_190606,IEDB_225177,IEDB_885823,SB_7
Methods: 13C NMR, 1H NMR, GLC-MS, NMR-2D, SDS-PAGE, sugar analysis, ELISA, MALDI-MS, HPLC, ion-exchange chromatography, conjugation, immunofluorescence labeling, opsonophagocytic assay
Comments, role: major polymer (trisaccharide) were obtained from St. mutans serotype k strains: OM42X (NRCC # 6749), OM88X (NRCC # 6748), OM98X (NRCC # 6747).
Related record ID(s): 12799, 12801, 12802, 12984
NCBI Taxonomy refs (TaxIDs): 1309Reference(s) to other database(s): GTC:G82668EV, GlycomeDB:
16014
Show glycosyltransferases
NMR conditions: at 298 K
[as TSV]
13C NMR data:
Linkage Residue C1 C2 C3 C4 C5 C6
2 aLRhap 102.6 70.9 78.5 72.7 70.3 17.7
3 aDGalp 96.8 69.0 70.3 70.2 71.7 61.9
aLRhap 101.9 74.7 76.0 71.7 70.4 18.0
1H NMR data:
Linkage Residue H1 H2 H3 H4 H5 H6
2 aLRhap 5.12 4.17 3.88 3.57 3.76 1.29
3 aDGalp 5.13 3.89 3.92 4.02 4.20 3.74-3.74
aLRhap 5.21 4.30 4.01 3.65 3.88 1.36
1H/13C HSQC data:
Linkage Residue C1/H1 C2/H2 C3/H3 C4/H4 C5/H5 C6/H6
2 aLRhap 102.6/5.12 70.9/4.17 78.5/3.88 72.7/3.57 70.3/3.76 17.7/1.29
3 aDGalp 96.8/5.13 69.0/3.89 70.3/3.92 70.2/4.02 71.7/4.20 61.9/3.74-3.74
aLRhap 101.9/5.21 74.7/4.30 76.0/4.01 71.7/3.65 70.4/3.88 18.0/1.36
1H NMR data:
| Linkage | Residue | H1 | H2 | H3 | H4 | H5 | H6 |
| 2 | aLRhap | 5.12 | 4.17 | 3.88 | 3.57 | 3.76 | 1.29 |
| 3 | aDGalp | 5.13 | 3.89 | 3.92 | 4.02 | 4.20 | 3.74 3.74 |
| | aLRhap | 5.21 | 4.30 | 4.01 | 3.65 | 3.88 | 1.36 |
|
13C NMR data:
| Linkage | Residue | C1 | C2 | C3 | C4 | C5 | C6 |
| 2 | aLRhap | 102.6 | 70.9 | 78.5 | 72.7 | 70.3 | 17.7 |
| 3 | aDGalp | 96.8 | 69.0 | 70.3 | 70.2 | 71.7 | 61.9 |
| | aLRhap | 101.9 | 74.7 | 76.0 | 71.7 | 70.4 | 18.0 |
|
There is only one chemically distinct structure: